Ads
related to: news fda
Search results
FDA considers weekly insulin for diabetics - ABC Columbia
ABC Columbia· 3 days agoA U.S. Food and Drug Administration Advisory Committee is considering the benefits of a weekly...
FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men
San Jose Mercury News· 5 hours agoAdvocates, lawmakers, and groups focused on removing barriers to cornea donations, in particular,...
Lab industry sues to stop FDA’s new LDT rule
MedTech Dive via Yahoo Finance· 10 hours agoDive. “In the interim, companies will be assessing whether or not to invest in building the systems and compliance programs needed to prepare for the...
FDA Approves Nonstimulant Liquid Onyda XR for ADHD
Medscape· 18 hours agoThe centrally acting alpha2-adrenergic agonist allows for nighttime dosing and can be used with stimulants, the drug's manufacturer says.
FDA issues updated Class III recall on Fiji bottled water
WJAX via Yahoo News· 22 hours agoFiji Natural Artesian Water has recalled nearly 1.9 million bottles of water after testing in March...
New GLP-1 Supply Tracker: Where to Find Weight Loss Drugs Ozempic, Wegovy Near You
InvestorPlace· 7 hours agoA new GLP-1 supply tracker is online that can help find Ozempic near you while also providing supply...
FDA approves interchangeable biosimilar to Soliris
Becker’s Hospital Review· 2 days agoThe FDA has approved Bkemv as the first interchangeable biosimilar to Soliris to treat certain rare diseases. Bkemv is approved for the treatment of patients with paroxysmal ...
Exact Sciences stock drops as Guardant Health test supported by FDA panel By Investing.com
Investing.com· 6 days agoExact Sciences (NASDAQ:EXAS) stock dropped Friday after news that the Molecular and Clinical...
FDA prioritizes review of Jazz Pharmaceuticals' new cancer therapy By Investing.com
Investing.com· 1 day agoJazz Pharmaceuticals (NASDAQ:JAZZ) announced that the U.S. Food and Drug Administration (FDA) has...
Biotech Stocks Facing FDA Decision In June 2024
RTT News· 13 hours agoNotably, in June, Eli Lilly's investigational antibody therapy Donanemab for treating early Alzheimer's will be reviewed by an advisory panel. Before delving into the drugs awaiting
